Jpmorgan Chase & CO Titan Medical Inc Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.39 - $0.84 $6,396 - $13,776	-16,400 Reduced 14.56%	96,200 $64,000
Q3 2022 Nov 14, 2022	SELL	$0.44 - $0.64 $5,720 - $8,320	-13,000 Reduced 10.35%	112,600 $608,000
Q2 2022 Aug 11, 2022	SELL	$0.39 - $0.6 $390 - $600	-1,000 Reduced 0.79%	125,600 $64,000
Q1 2022 May 11, 2022	BUY	$0.48 - $0.66 $25,200 - $34,650	52,500 Added 70.85%	126,600 $67,000
Q4 2021 Feb 10, 2022	SELL	$0.61 - $1.73 $1,098 - $3,114	-1,800 Reduced 2.37%	74,100 $46,000
Q3 2021 Nov 12, 2021	BUY	$1.52 - $1.8 $115,368 - $136,620	75,900 New	75,900 $115,000

225K

Ticker TMDI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 111,545,000
Market Cap $16.7M
Description
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition visio...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.